In this issue, Dang et al. (2011) report a role for the hypoxia-induced transcription factor HIF-1a in regulating the differentiation of T cell subsets that impact both inflammation and its resolution. Their findings illustrate how metabolic signals can alter the balance between inflammation and tolerance and present a potential therapeutic opportunity for the treatment of diseases associated with chronic inflammation.
For two decades, a central paradigm has been that pathogen-stimulated innate immune cells produce cytokines to educate the adaptive T helper (Th) response in order to appropriately deal with foreign antigens. For example, the Th17 subset, defined by the expression of the proinflammatory cytokine IL-17A and transcription factor RORgt, is generated in response to gut infections such as Citrobacter rodentium (Mangan et al., 2006) , as well as normal gut constituents such as segmented filamentous bacteria (Ivanov et al., 2009) . By contrast, peripheral generation of induced regulatory T cells (iTreg) suppresses immune responses and facilitates tolerance to commensal microbiota (Round and Mazmanian, 2010 ). The mechanism underlying the selection of these T cell subsets of opposing function centers on the level of induction of interleukin 6 (IL-6) in the microenvironment. In conjunction with TGFb, high levels of IL-6 facilitate Th17 development, whereas low levels result in iTreg generation (Bettelli et al., 2006; Mangan et al., 2006) . Though the role of cytokines in the microenvironment is well appreciated in the differentiation of both Th17 cells and iTregs, how other cues are sensed and interpreted is an area of much interest. In this issue, Dang and colleagues (Dang et al., 2011) reveal a mechanism by which an environmental cue, hypoxia, facilitates differentiation toward the proinflammatory Th17 phenotype while simultaneously inhibiting differentiation toward tolerogenic iTregs. The mechanism centers on the T cell intrinsic upregulation of the transcription factor hypoxia-inducible factor 1a (HIF-1a), a key sensor of hypoxia that mediates the metabolic switch from oxidative phosphorylation to anaerobic glycolysis.
A potential role for HIF-1a in Th17 biology was initially suggested by studies in tumor cells showing that HIF-1a expression is dependent on Stat3, a key transcription factor for Th17 differentiation. Dang et al. first show that HIF-1a is expressed in T cells upon T cell receptor (TCR) stimulation and that its expression is further induced during hypoxia as well as downstream of IL-6-and Stat3-dependent Th17 differentiation. Importantly, HIF-1a appears to be both necessary and sufficient for Th17 development, as overexpression could induce Th17 cells without the proper cytokine milieu, and HIF-1a deficiency specifically blocked Th17 development, but not Th1 or Th2 development. The mechanism by which HIF-1a controls Th17 expression is centered on RORgt, a transcription factor that is critical to Th17 differentiation. HIF-1a binds to the promoter of the RORgt gene and induces its transcriptional upregulation. In addition, HIF-1a forms a complex with RORgt and p300, which binds to the promoter of IL-17A, the signature Th17 cytokine, and triggers its expression.
Strikingly, Dang et al. also reveal a role for HIF-1a as a negative regulator of iTreg differentiation. T cells that are deficient in HIF-1a exhibited increased expression of the transcription factor Foxp3, which is essential for Treg development and function. HIF-1a appears to utilize a direct mechanism of action, binding to Foxp3 and targeting it for ubiquitin-mediated proteolysis. Because Foxp3 may operate in a feed-forward loop to stabilize its own expression (Gavin et al., 2007) and inhibit RORgt (Yang et al., 2008) , a decrease in Foxp3 protein levels can result in failure to become bona fide iTregs. In the differentiation of these Th subsets with opposing functions, the expression of HIF-1a may tip the balance point via its concomitant and opposite actions on transcription factors that are essential for the development of each subset. Thus, selection of Th17 versus iTreg cells may be closer to a digital, rather than analog, interpretation of HIF-1a levels. Once a critical level of HIF-1a and RORgt expression is reached, the cell becomes Th17, contributing to an inflammatory environment, which would increase hypoxia and further serve to upregulate HIF-1a.
Dang et al. show that hypoxia facilitates Th17 generation in vitro and further observe that the absence of HIF-1a impairs the generation of Th17 cells in vivo, resulting in resistance to experimental autoimmune encephalomyelitis (EAE). The absence of HIF-1a also results in increased frequency of Tregs in the gut. It is interesting to note that the gut, which is considered to be relatively hypoxic, is also the site where most Th17 cells are found in normal mice. A hypoxic environment in itself does not appear to be sufficient, as Th17 cells are greatly reduced in the absence of specific strains of commensal gut bacteria (Ivanov et al., 2009) . Whether bacterial strains associated with Th17 development affect the oxygen tension in the gut is unknown. Indeed, the question of how microbiota affects the gut microenvironment and how that, in turn, affects immune cells residing there is only beginning to be explored. HIF-1a is expressed in T cells under nonhypoxic conditions, complicating the interpretation of results using HIF-1a deficient cells to address the role of hypoxia in physiological settings. Thus, the increased frequency of Tregs in the gut of HIF-1a-deficient mice may be related to the basal role of HIF-1a in Th17 versus iTreg development rather than the inability to upregulate HIF-1a in response to hypoxia and the ensuing increase in Th17 cytokine production. Because HIF-1a expression can be upregulated by both cytokines and hypoxia, further studies will be necessary to examine the relative contributions of each to the differentiation of Th17 and iTreg cells.
Roles for metabolic signaling pathways in Th cell differentiation have been suggested by other studies. A study of mTOR complexes, known metabolic sensors, revealed distinct roles of mTORC1 and -2 in Th1/Th17 and Th2 differentiation, respectively (Delgoffe et al., 2011) . Similar to Dang et al., another study of HIF-1a suggested that it is involved in Th17 and iTreg differentiation but ascribed the role of HIF-1a to upregulation of glycolysis (Shi et al., 2011) and not as a direct effect of HIF-1a on RORgt and Foxp3. Further studies will be required to reconcile these differences. Nevertheless, it is clear that environmental signals should be included in the paradigm of Th differentiation.
The findings by Dang et al. lead to a model in which hypoxia, resulting from inflammation or from a predisposed local microenvironment, plays a pivotal role in the Th17/iTreg decision. Interestingly, this model represents a positive feedback loop in which HIF-1a induction leads to Th17 differentiation which, in turn, causes more inflammation, leading to greater hypoxia and HIF-1a (Figure 1) . In order to re-establish immune homeostasis, the antigenic insult inciting the inflammation would need to be destroyed. In the case of immune responses to commensal bacteria in the gut, the large reservoir of bacteria in the lumen of the colon may make it impossible to completely eliminate the source of antigen. This would then lead to chronic inflammation and inflammatory bowel disease (IBD). Interestingly, human IBD is associated with increased Th17 responses as well as genetic polymorphisms of genes related to Th17 biology (Abraham and Cho, 2009) . Targeting HIF-1a via diminishing local hypoxia or inhibition using pharmacologic agents may therefore be useful in the treatment of IBD. Though it remains to be established whether HIF-1a modulation can alter the function of established Th17 cells, ROR ligands have recently been reported to inhibit IL-17 production in differentiated Th17 cells (Solt et al., 2011) . One potential advantage of HIF-1a inhibitors compared with ROR ligands is that it would be predicted to block Th17 development and concomitantly favor the generation of tolerogenic Treg cells: a doublepronged attack against immune-mediated pathology. T cell receptor (TCR) signaling, hypoxia via mTOR, and IL-6 via Stat3 all contribute to the induction of HIF-1a, a transcription factor that induces expression of RORgt, a key regulator of Th17 differentiation. HIF-1a further supports Th17 function by binding in a complex with RORgt and p300 to allow expression of the canonical Th17 cytokine IL-17A. Moreover, HIF-1a also promotes degradation of the transcription Foxp3, a key transcription factor that promotes the Treg lineage via a proposed ubiquitination pathway. In this way, the level of HIF-1a might induce, in a ''digital'' fashion, a molecular switch from iTreg to Th17 differentiation. Because the local environment of the gut and that of sites of inflammation are associated with hypoxia, these conditions would be hypothesized to promote the development of proinflammatory Th17 cells. Th17 cells via the production of IL-17A would further enhance the inflammatory process resulting in increased hypoxia, thereby acting as a feed-forward loop. If the source of antigenic stimulation (either from pathogenic or commensal organisms) cannot be eliminated by the Th17 response, this could result in chronic inflammatory conditions such as inflammatory bowel disease.
